Ambaw Bellete - 24 Jan 2024 Form 3 Insider Report for CG Oncology, Inc. (CGON)

Role
President and COO
Signature
/s/ Corleen Roche, Attorney-in-Fact for Ambaw Bellete
Issuer symbol
CGON
Transactions as of
24 Jan 2024
Net transactions value
$0
Form type
3
Filing time
24 Jan 2024, 21:11:26 UTC
Next filing
07 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGON Stock Option 24 Jan 2024 Common Stock 52,438 $1.82 Direct F1
holding CGON Stock Option 24 Jan 2024 Common Stock 432,311 $3.72 Direct F2
holding CGON Stock Option 24 Jan 2024 Common Stock 29,365 $3.72 Direct F3
holding CGON Stock Option 24 Jan 2024 Common Stock 52,438 $12.59 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on June 1, 2023, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.
F2 The stock option vests as to 25% of the underlying shares on July 9, 2024, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.
F3 The stock option vests at the closing of the Issuer's initial public offering.
F4 The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.

Remarks:

Exhibit 24 - Power of Attorney.